Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Autor: Dreyling M; Department of Medicine III, University Hospital - LMU Munich, Munich, Germany., Campo E; Hematopathology Section, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain., Hermine O; Department of Hematology, Imagine Institute and Descartes University, INSERM U1163 and CNRS ERL 8564, Necker Hospital, Paris, France., Jerkeman M; Department of Hematology, University Lund, Lund, Sweden., Le Gouill S; CHU de Nantes, Service d'Hématologie Clinique, Université de Nantes, Nantes, France., Rule S; Peninsula School of Medicine and Dentistry, University of Plymouth, Plymouth, UK., Shpilberg O; Institute of Hematology, Assuta Medical Center, Tel-Aviv, Israel., Walewski J; Department of Lymphoid Malignancy, Maria Sklodowska-Curie Institute and Oncology Centre, Warsaw, Poland., Ladetto M; Divisione di Ematologia, Azienda Ospedaliera Santi Antonio e Biagio e Cesare Arrigo, Alessandria, Italy.
Jazyk: angličtina
Zdroj: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2017 Jul 01; Vol. 28 (suppl_4), pp. iv62-iv71.
DOI: 10.1093/annonc/mdx223
Databáze: MEDLINE